Insider Trading History of Grimm Donald W

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) by Grimm Donald W since 2007. The trader's CIK number is 1208809. At the time of the last reporting, Grimm Donald W was the Director of Invitrogen Corp. (stock ticker symbol IVGN). Also see all insider trading activities at Invitrogen Corp.


Yearly summary of insider trading at Invitrogen Corp (LIFE) by Grimm Donald W

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2012 LIFE 0 $0 12,052 $577,752 0 $0
2011 LIFE 0 $0 0 $0 4,052 $150,774
2010 LIFE 0 $0 20,000 $929,920 20,000 $666,200
2009 LIFE 0 $0 20,000 $933,259 20,000 $578,800
2007 LIFE 0 $0 27,100 $2,357,948 31,900 $1,634,197


Insider trading of Invitrogen Corp (LIFE) by Grimm Donald W

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2012-11-19 LIFE Sale 4,052 47.86 193,912
2012-11-20 LIFE Sale 8,000 47.98 383,840
2011-10-03 LIFE Option Ex 4,052 37.21 150,774
2010-09-09 LIFE Option Ex 20,000 33.31 666,200
2010-09-09 LIFE Sale 20,000 46.50 929,920
2009-09-09 LIFE Option Ex 20,000 28.94 578,800
2009-09-09 LIFE Sale 20,000 46.66 933,259
2007-11-07 IVGN Sale 4,500 91.01 409,563
2007-11-07 IVGN Option Ex 20,500 67.65 1,386,825
2007-11-07 IVGN Sale 4,000 91.02 364,088
2007-11-07 IVGN Option Ex 200 91.02 18,204
2007-11-07 IVGN Sale 2,700 91.02 245,748
2007-11-07 IVGN Option Ex 300 91.02 27,304
2007-11-07 IVGN Sale 5,121 90.99 465,949
2007-11-07 IVGN Option Ex 900 90.96 81,864
2007-11-07 IVGN Sale 1,779 90.84 161,600
2005-05-18 IVGN Sale 9,000 79.00 711,000
2005-05-18 IVGN Option Ex 10,000 12.00 120,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Grimm Donald W (Director of Invitrogen Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.